Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Company Information for

SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

1 Kingdom Street, London, W2 6BD,
Company Registration Number
02486738
Private Limited Company
Active - Proposal to Strike off

Company Overview

About Shire Pharmaceutical Development Ltd
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED was founded on 1990-03-29 and has its registered office in London. The organisation's status is listed as "Active - Proposal to Strike off". Shire Pharmaceutical Development Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as FULL
  • Annual turnover is £6.5 million or more
  • The balance sheet total is £ 3.26 million or more
  • Employs 50 or more employees
  • May be publically listed
  • May be a member of a group of companies meeting any of the above criteria
Key Data
Company Name
SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
 
Legal Registered Office
1 Kingdom Street
London
W2 6BD
Other companies in RG24
 
Filing Information
Company Number 02486738
Company ID Number 02486738
Date formed 1990-03-29
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active - Proposal to Strike off
Lastest accounts 2021-03-31
Account next due 31/03/2023
Latest return 28/06/2016
Return next due 26/07/2017
Type of accounts FULL
Last Datalog update: 2023-03-15 03:59:33
Primary Source:Companies House
There are multiple companies registered at this address, the registered address may be the accountant's offices for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
Companies with same name SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
The following companies were found which have the same name as SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED. These may be the same company in different jurisdictions
  Registered addressLast known statusFormation date
Shire Pharmaceutical Development LLC Delaware Unknown
Shire Pharmaceutical Development Inc Maryland Unknown

Company Officers of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED

Current Directors
Officer Role Date Appointed
SHIRE CORPORATE SERVICES LIMITED
 Company Secretary 2018-03-01
FEARGHAS MACGILP KERR CARRUTHERS
 Director 2013-05-20
KENTARO SHIRAHATA
 Director 2018-06-30
STEPHEN PHILIP WILLIAMS
 Director 2018-08-15
Previous Officers
Officer Role Date Appointed Date Resigned
JONATHAN IVAN WILLIAM WEBB
 Director 2017-04-04 2018-07-04
OLIVER STRAWBRIDGE
 Company Secretary 2015-11-18 2018-03-01
AMANDA MILLER
 Director 2014-05-13 2017-02-20
ANTHONY JAMES GUTHRIE
 Company Secretary 2008-06-18 2015-09-30
DANIEL WILLIAM DAVID HARTLEY
 Director 2008-06-18 2014-05-13
JOSEPHINE JOAN CHRISTINE FERDINANDO
 Director 2008-08-06 2013-09-30
PATRICK NORRIS CLEMENTS
 Director 2008-06-18 2013-05-20
TATJANA ANNI HILDE MAY
 Company Secretary 2001-05-01 2008-06-18
MATTHEW WILLIAM EMMENS
 Director 2003-03-12 2008-06-18
JOSEPH RUS
 Director 2004-06-30 2008-06-18
ANGUS CHARLES RUSSELL
 Director 1999-12-14 2008-06-18
JOSEPH WILSON TOTTEN
 Director 1999-05-10 2004-06-30
ROLF STAHEL
 Director 1994-03-07 2003-03-12
ANGUS CHARLES RUSSELL
 Company Secretary 2001-04-05 2001-04-30
NEIL CHARLES HARRIS
 Company Secretary 1995-12-01 2001-04-04
TREVOR DAVIS
 Director 1994-01-27 2000-05-11
STEPHEN ANTONY STAMP
 Director 1994-04-11 1999-12-13
JAMES ROBERT MURRAY
 Director 1991-05-30 1999-02-28
CLIVE JOHN COLLINS
 Director 1991-10-23 1997-05-29
JANET CLARKE
 Director 1991-07-31 1996-06-19
JOHN ANTHONY KANIS
 Director 1991-05-30 1996-04-03
PETER MCPARTLAND
 Director 1991-05-30 1996-02-15
ANDREW FIRTH MCLEAN
 Company Secretary 1993-10-27 1995-11-30
HARRY THOMAS STRATFORD
 Director 1991-05-30 1994-03-07
PETER MCPARTLAND
 Company Secretary 1991-05-30 1993-10-27
HENRY SIMON
 Director 1991-05-30 1993-07-21

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
SHIRE CORPORATE SERVICES LIMITED NPS PHARMA UK LIMITED Company Secretary 2018-03-14 CURRENT 2006-11-13 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE BIOPHARMACEUTICALS HOLDINGS Company Secretary 2018-03-13 CURRENT 2005-06-27 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE GLOBAL FINANCE Company Secretary 2018-03-13 CURRENT 2005-04-08 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE BIOTECH UK HOLDINGS LIMITED Company Secretary 2018-03-01 CURRENT 2017-09-04 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED DYAX LTD Company Secretary 2018-03-01 CURRENT 2014-03-28 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED BAXALTA UK HOLDCO LIMITED Company Secretary 2018-03-01 CURRENT 2014-10-03 Active
SHIRE CORPORATE SERVICES LIMITED BAXALTA UK LIMITED Company Secretary 2018-03-01 CURRENT 2014-10-03 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED RYBAR LABORATORIES LIMITED Company Secretary 2018-03-01 CURRENT 1941-04-18 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE PHARMACEUTICALS GROUP Company Secretary 2018-03-01 CURRENT 1994-01-01 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SPARKLEFLAME LIMITED Company Secretary 2018-03-01 CURRENT 1995-10-17 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE HOLDINGS EUROPE LIMITED Company Secretary 2018-03-01 CURRENT 1996-02-13 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE HUMAN GENETIC THERAPIES UK LIMITED Company Secretary 2018-03-01 CURRENT 2000-08-23 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE HUMAN GENETIC THERAPIES LIMITED Company Secretary 2018-03-01 CURRENT 2001-06-28 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE PHARMACEUTICALS SERVICES LIMITED Company Secretary 2018-03-01 CURRENT 2002-04-18 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE HOLDINGS UK LIMITED Company Secretary 2018-03-01 CURRENT 2003-02-14 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE EUROPE FINANCE Company Secretary 2018-03-01 CURRENT 2004-07-30 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE HOLDINGS UK CANADA LIMITED Company Secretary 2018-03-01 CURRENT 2006-10-12 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED VIROPHARMA LIMITED Company Secretary 2018-03-01 CURRENT 2007-05-14 Active
SHIRE CORPORATE SERVICES LIMITED SHIRE US INVESTMENTS Company Secretary 2018-03-01 CURRENT 2007-06-11 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE EUROPE LIMITED Company Secretary 2018-03-01 CURRENT 2008-04-10 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED BAXALTA UK INVESTMENTS LTD. Company Secretary 2018-03-01 CURRENT 2002-07-23 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED AURALIS LIMITED Company Secretary 2018-03-01 CURRENT 2005-01-18 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED THE ENDOCRINE CENTRE LIMITED Company Secretary 2018-03-01 CURRENT 1991-04-22 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE PHARMACEUTICAL CONTRACTS LIMITED Company Secretary 2018-03-01 CURRENT 1986-06-02 Active
SHIRE CORPORATE SERVICES LIMITED SHIRE PHARMACEUTICALS LIMITED Company Secretary 2018-03-01 CURRENT 1986-06-26 Active
SHIRE CORPORATE SERVICES LIMITED MONMOUTH PHARMACEUTICALS LIMITED Company Secretary 2018-03-01 CURRENT 1984-04-17 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY Company Secretary 2018-03-01 CURRENT 2001-12-20 Liquidation
SHIRE CORPORATE SERVICES LIMITED SHIRE UK INVESTMENTS LIMITED Company Secretary 2018-03-01 CURRENT 2005-08-22 Active - Proposal to Strike off
SHIRE CORPORATE SERVICES LIMITED LUMENA PHARMA UK LIMITED Company Secretary 2018-03-01 CURRENT 2013-03-21 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS DYAX LTD Director 2017-12-31 CURRENT 2014-03-28 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS BAXALTA UK HOLDCO LIMITED Director 2017-12-31 CURRENT 2014-10-03 Active
FEARGHAS MACGILP KERR CARRUTHERS BAXALTA UK LIMITED Director 2017-12-31 CURRENT 2014-10-03 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE PHARMACEUTICALS GROUP Director 2017-03-31 CURRENT 1994-01-01 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE PHARMACEUTICALS SERVICES LIMITED Director 2017-03-31 CURRENT 2002-04-18 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE HOLDINGS IRELAND Director 2013-05-20 CURRENT 2008-06-04 Active
FEARGHAS MACGILP KERR CARRUTHERS SHIRE HOLDINGS EUROPE LIMITED Director 2013-05-20 CURRENT 1996-02-13 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE HOLDINGS UK LIMITED Director 2013-05-20 CURRENT 2003-02-14 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE BIOPHARMACEUTICALS HOLDINGS Director 2013-05-20 CURRENT 2005-06-27 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE HOLDINGS UK CANADA LIMITED Director 2013-05-20 CURRENT 2006-10-12 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE US INVESTMENTS Director 2013-05-20 CURRENT 2007-06-11 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE EUROPE LIMITED Director 2013-05-20 CURRENT 2008-04-10 Active - Proposal to Strike off
FEARGHAS MACGILP KERR CARRUTHERS SHIRE INVESTMENTS & FINANCE (U.K.) COMPANY Director 2013-05-20 CURRENT 2001-12-20 Liquidation
FEARGHAS MACGILP KERR CARRUTHERS SHIRE UK INVESTMENTS LIMITED Director 2013-05-20 CURRENT 2005-08-22 Active - Proposal to Strike off
KENTARO SHIRAHATA SHIRE BIOPHARMACEUTICALS HOLDINGS Director 2018-06-30 CURRENT 2005-06-27 Active - Proposal to Strike off
KENTARO SHIRAHATA SHIRE GLOBAL FINANCE Director 2018-06-30 CURRENT 2005-04-08 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS TAKEDA CORPORATE SERVICES LIMITED Director 2017-10-19 CURRENT 2017-10-19 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE EUROPE FINANCE Director 2017-09-05 CURRENT 2004-07-30 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE BIOTECH UK HOLDINGS LIMITED Director 2017-09-04 CURRENT 2017-09-04 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE HOLDINGS UK CANADA LIMITED Director 2017-06-05 CURRENT 2006-10-12 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS RYBAR LABORATORIES LIMITED Director 2017-04-05 CURRENT 1941-04-18 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SPARKLEFLAME LIMITED Director 2017-04-05 CURRENT 1995-10-17 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS VIROPHARMA LIMITED Director 2017-04-05 CURRENT 2007-05-14 Active
STEPHEN PHILIP WILLIAMS THE ENDOCRINE CENTRE LIMITED Director 2017-04-05 CURRENT 1991-04-22 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS MONMOUTH PHARMACEUTICALS LIMITED Director 2017-04-05 CURRENT 1984-04-17 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE US INVESTMENTS Director 2017-04-04 CURRENT 2007-06-11 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE UK INVESTMENTS LIMITED Director 2017-04-04 CURRENT 2005-08-22 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE HUMAN GENETIC THERAPIES UK LIMITED Director 2017-03-31 CURRENT 2000-08-23 Active - Proposal to Strike off
STEPHEN PHILIP WILLIAMS SHIRE HUMAN GENETIC THERAPIES LIMITED Director 2017-03-31 CURRENT 2001-06-28 Active - Proposal to Strike off

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2023-03-21SECOND GAZETTE not voluntary dissolution
2023-01-03FIRST GAZETTE notice for voluntary strike-off
2023-01-03GAZ1(A)FIRST GAZETTE notice for voluntary strike-off
2022-12-22Application to strike the company off the register
2022-12-22DS01Application to strike the company off the register
2022-11-10APPOINTMENT TERMINATED, DIRECTOR MARK GIBBONS
2022-11-10APPOINTMENT TERMINATED, DIRECTOR MARK GIBBONS
2022-11-10TM01APPOINTMENT TERMINATED, DIRECTOR MARK GIBBONS
2022-07-04CONFIRMATION STATEMENT MADE ON 28/06/22, WITH UPDATES
2022-07-04CS01CONFIRMATION STATEMENT MADE ON 28/06/22, WITH UPDATES
2022-05-19AAFULL ACCOUNTS MADE UP TO 31/03/21
2022-03-21AP01DIRECTOR APPOINTED PETER MICHAEL GRUBIN
2022-03-21TM01APPOINTMENT TERMINATED, DIRECTOR KENTARO SHIRAHATA
2021-11-11SH19Statement of capital on 2021-11-11 GBP 1
2021-11-11SH20Statement by Directors
2021-11-11CAP-SSSolvency Statement dated 09/11/21
2021-11-11RES06Resolutions passed:
  • Resolution of reduction in issued share capital
2021-07-09CS01CONFIRMATION STATEMENT MADE ON 28/06/21, WITH NO UPDATES
2021-04-17AAFULL ACCOUNTS MADE UP TO 31/03/20
2020-12-01AP01DIRECTOR APPOINTED MR MARC STUART PAGE
2020-12-01TM01APPOINTMENT TERMINATED, DIRECTOR SARAH LUCY CHARSLEY
2020-07-02CS01CONFIRMATION STATEMENT MADE ON 28/06/20, WITH NO UPDATES
2020-04-28CH04SECRETARY'S DETAILS CHNAGED FOR SHIRE CORPORATE SERVICES LIMITED on 2020-04-28
2020-03-04AA01Current accounting period extended from 31/12/19 TO 31/03/20
2020-03-04AA01Current accounting period extended from 31/12/19 TO 31/03/20
2019-12-05AUDAUDITOR'S RESIGNATION
2019-10-10AAFULL ACCOUNTS MADE UP TO 31/12/18
2019-07-10CS01CONFIRMATION STATEMENT MADE ON 28/06/19, WITH NO UPDATES
2019-03-04AP01DIRECTOR APPOINTED MRS SARAH LUCY CHARSLEY
2019-03-04TM01APPOINTMENT TERMINATED, DIRECTOR STEPHEN PHILIP WILLIAMS
2018-10-06AAFULL ACCOUNTS MADE UP TO 31/12/17
2018-08-28AP01DIRECTOR APPOINTED MR STEPHEN PHILIP WILLIAMS
2018-07-04AP01DIRECTOR APPOINTED MR KENTARO SHIRAHATA
2018-07-04TM01APPOINTMENT TERMINATED, DIRECTOR JONATHAN IVAN WILLIAM WEBB
2018-07-04CS01CONFIRMATION STATEMENT MADE ON 28/06/18, WITH NO UPDATES
2018-03-14TM02Termination of appointment of Oliver Strawbridge on 2018-03-01
2018-03-14AP04Appointment of Shire Corporate Services Limited as company secretary on 2018-03-01
2017-10-10AAFULL ACCOUNTS MADE UP TO 31/12/16
2017-08-10AD04Register(s) moved to registered office address 1 Kingdom Street London W2 6BD
2017-08-04PSC02Notification of Shire Pharmaceuticals Group as a person with significant control on 2016-04-06
2017-07-03LATEST SOC03/07/17 STATEMENT OF CAPITAL;GBP 230610990
2017-07-03CS01CONFIRMATION STATEMENT MADE ON 28/06/17, WITH UPDATES
2017-07-03AD01REGISTERED OFFICE CHANGED ON 03/07/17 FROM Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP
2017-05-08AP01DIRECTOR APPOINTED JONATHAN IVAN WILLIAM WEBB
2017-03-30TM01APPOINTMENT TERMINATED, DIRECTOR AMANDA MILLER
2017-02-22AD03Registers moved to registered inspection location of 1 Kingdom Street London W2 6BD
2017-02-21AD02Register inspection address changed to 1 Kingdom Street London W2 6BD
2017-01-05CH01DIRECTOR'S CHANGE OF PARTICULARS / FEARGHAS MACGILP KERR CARRUTHERS / 03/01/2017
2017-01-05CH01DIRECTOR'S CHANGE OF PARTICULARS / MRS AMANDA MILLER / 03/01/2017
2017-01-04CH03SECRETARY'S CHANGE OF PARTICULARS / MR OLIVER STRAWBRIDGE / 03/01/2017
2016-10-13AAFULL ACCOUNTS MADE UP TO 31/12/15
2016-07-23CH03SECRETARY'S CHANGE OF PARTICULARS / MR OLIVER STRAWBRIDGE / 28/06/2016
2016-06-29LATEST SOC29/06/16 STATEMENT OF CAPITAL;GBP 230610990
2016-06-29AR0128/06/16 FULL LIST
2016-03-31CH01DIRECTOR'S CHANGE OF PARTICULARS / MRS AMANDA MILLER / 11/03/2016
2015-11-19AP03SECRETARY APPOINTED MR OLIVER STRAWBRIDGE
2015-11-19AP03SECRETARY APPOINTED MR OLIVER STRAWBRIDGE
2015-10-13AAFULL ACCOUNTS MADE UP TO 31/12/14
2015-10-07TM02APPOINTMENT TERMINATED, SECRETARY ANTHONY GUTHRIE
2015-07-21LATEST SOC21/07/15 STATEMENT OF CAPITAL;GBP 230610990
2015-07-21AR0130/06/15 FULL LIST
2014-10-06AAFULL ACCOUNTS MADE UP TO 31/12/13
2014-07-28LATEST SOC28/07/14 STATEMENT OF CAPITAL;GBP 230610990
2014-07-28AR0130/06/14 FULL LIST
2014-05-14TM01APPOINTMENT TERMINATED, DIRECTOR DANIEL HARTLEY
2014-05-14AP01DIRECTOR APPOINTED MRS AMANDA MILLER
2013-10-03TM01APPOINTMENT TERMINATED, DIRECTOR JOSEPHINE FERDINANDO
2013-09-26AAFULL ACCOUNTS MADE UP TO 31/12/12
2013-07-09AR0130/06/13 FULL LIST
2013-05-30AP01DIRECTOR APPOINTED FEARGHAS MACGILP KERR CARRUTHERS
2013-05-30TM01APPOINTMENT TERMINATED, DIRECTOR PATRICK CLEMENTS
2012-09-20AAFULL ACCOUNTS MADE UP TO 31/12/11
2012-07-27AR0130/06/12 FULL LIST
2011-09-09AAFULL ACCOUNTS MADE UP TO 31/12/10
2011-07-05AR0130/06/11 FULL LIST
2011-07-05CH01DIRECTOR'S CHANGE OF PARTICULARS / JOSEPHINE JOAN CHRISTINE FERDINANDO / 31/12/2010
2010-08-03AR0130/06/10 FULL LIST
2010-07-15AAFULL ACCOUNTS MADE UP TO 31/12/09
2010-07-07CC04STATEMENT OF COMPANY'S OBJECTS
2010-07-07RES01ADOPT ARTICLES 10/05/2010
2009-10-23AAFULL ACCOUNTS MADE UP TO 31/12/08
2009-06-30363aRETURN MADE UP TO 30/06/09; FULL LIST OF MEMBERS
2008-10-30288cSECRETARY'S CHANGE OF PARTICULARS / ANTHONY GUTHRIE / 30/10/2008
2008-10-23123NC INC ALREADY ADJUSTED 09/10/08
2008-10-23RES10AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES
2008-10-23RES04GBP NC 6100000/230610990 09/09/2008
2008-10-2388(2)AD 09/10/08 GBP SI 224510990@1=224510990 GBP IC 6100000/230610990
2008-08-13288aDIRECTOR APPOINTED JOSEPHINE JOAN CHRISTINE FERDINANDO
2008-07-29363aRETURN MADE UP TO 30/06/08; FULL LIST OF MEMBERS; AMEND
2008-07-10288bAPPOINTMENT TERMINATED DIRECTOR ANGUS RUSSELL
2008-07-10288bAPPOINTMENT TERMINATED DIRECTOR JOSEPH RUS
2008-07-10288aSECRETARY APPOINTED ANTHONY JAMES GUTHRIE
2008-07-10288bAPPOINTMENT TERMINATED SECRETARY TATJANA MAY
2008-07-10288bAPPOINTMENT TERMINATED DIRECTOR MATTHEW EMMENS
2008-07-10288aDIRECTOR APPOINTED DANIEL WILLIAM DAVID HARTLEY
2008-07-10288aDIRECTOR APPOINTED PATRICK NORRIS CLEMENTS
2008-07-04363aRETURN MADE UP TO 30/06/08; FULL LIST OF MEMBERS
2008-04-23AAFULL ACCOUNTS MADE UP TO 31/12/07
2007-09-20AAFULL ACCOUNTS MADE UP TO 31/12/06
2007-07-04363aRETURN MADE UP TO 30/06/07; FULL LIST OF MEMBERS
2006-11-03AAFULL ACCOUNTS MADE UP TO 31/12/05
2006-08-08363sRETURN MADE UP TO 30/06/06; FULL LIST OF MEMBERS
2005-12-08288cSECRETARY'S PARTICULARS CHANGED
2005-12-07288cDIRECTOR'S PARTICULARS CHANGED
2005-12-07AAFULL ACCOUNTS MADE UP TO 31/12/04
2005-12-07288cDIRECTOR'S PARTICULARS CHANGED
2005-11-09244DELIVERY EXT'D 3 MTH 31/12/04
2005-08-03363(288)DIRECTOR'S PARTICULARS CHANGED
2005-08-03363sRETURN MADE UP TO 30/06/05; FULL LIST OF MEMBERS
2004-11-01AAFULL ACCOUNTS MADE UP TO 31/12/03
2004-07-15288aNEW DIRECTOR APPOINTED
2004-07-15363sRETURN MADE UP TO 30/06/04; FULL LIST OF MEMBERS
2004-07-15288bDIRECTOR RESIGNED
2004-07-15288cDIRECTOR'S PARTICULARS CHANGED
2004-07-15363(288)DIRECTOR RESIGNED
2003-11-04AAFULL ACCOUNTS MADE UP TO 31/12/02
2003-07-10363(288)DIRECTOR'S PARTICULARS CHANGED
2003-07-10363sRETURN MADE UP TO 30/06/03; FULL LIST OF MEMBERS
2003-04-16288aNEW DIRECTOR APPOINTED
2003-04-14288bDIRECTOR RESIGNED
2003-02-27288cDIRECTOR'S PARTICULARS CHANGED
2002-08-10AUDAUDITOR'S RESIGNATION
2002-08-09AAFULL ACCOUNTS MADE UP TO 31/12/01
2002-07-10363sRETURN MADE UP TO 30/06/02; FULL LIST OF MEMBERS
2002-01-02403aDECLARATION OF SATISFACTION OF MORTGAGE/CHARGE
2001-12-28288cSECRETARY'S PARTICULARS CHANGED
2001-11-01AAFULL ACCOUNTS MADE UP TO 31/12/00
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72190 - Other research and experimental development on natural sciences and engineering




Licences & Regulatory approval
We could not find any licences issued to SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Share
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 2
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 2
Details of Mortgagee Charges
Charge Type Date of Charge Charge Status Mortgagee
DEBENTURE 1999-12-23 Satisfied DLJ CAPITAL FUNDING INC.
DEED POLL CONSTITUTING SECURED LOAN NOTES 1995 1994-12-19 Satisfied THE "NOTEHOLDERS"
Intangible Assets
Patents
We have not found any records of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED
Trademarks
We have not found any records of SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72190 - Other research and experimental development on natural sciences and engineering) as SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED are:

OAKLEA LTD. £ 237,880
TRL LIMITED £ 130,521
SGS MIS ENVIRONMENTAL LTD £ 18,077
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 13,354
WILDKNOWLEDGE LTD £ 8,604
FONTENERGY LTD £ 4,300
T-CUBED LTD £ 2,599
MARWELL WILDLIFE £ 1,089
CAMPDEN BRI (CHIPPING CAMPDEN) LIMITED £ 1,000
SITE ANALYTICAL SERVICES LIMITED £ 950
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
DNAE GROUP HOLDINGS LIMITED £ 8,493,738
TRL LIMITED £ 1,750,794
BUILDING RESEARCH ESTABLISHMENT LIMITED £ 1,586,573
MAGNOMATICS LIMITED £ 1,000,000
GILL RESEARCH & DEVELOPMENT LIMITED £ 996,786
EARLHAM INSTITUTE £ 750,000
CRAWLEY CREATURES LIMITED £ 561,896
SHEFFIELD HALLAM UNIVERSITY ENTERPRISES LTD £ 561,104
SITE ANALYTICAL SERVICES LIMITED £ 522,264
ALGAECYTES LIMITED £ 520,000
Outgoings
Business Rates/Property Tax
No properties were found where SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded SHIRE PHARMACEUTICAL DEVELOPMENT LIMITED any grants or awards.
Ownership
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.
    Other companies at postcode W2 6BD